Short-and long-term impact of an inpatient quality improvement initiative: Results of the cabg-gap practice improvement project

Journal of Cardiopulmonary Rehabilitation and Prevention

Volumn 33, Issue 4, 2013, Pages 212-219

  Thomas, Randal J ^a   Goel, Kashish ^a,c   Jumean, Marwan ^d   Mullany, Charles ^b   Lahr, Brian ^b   Gibbons, Ray ^b  

^a Division of Cardiovascular Diseases   (United States)

^b MAYO CLINIC   (United States)

^c WAYNE STATE UNIVERSITY   (United States)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CABG surgery; quality improvement; secondary prevention

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ENZYME INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGED; ARTICLE; BYPASS SURGERY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SURGERY; CORONARY ARTERY; DRUG THERAPY; FEMALE; HEALTH CARE QUALITY; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT CARE; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; PROPHYLAXIS;

ADRENERGIC BETA-ANTAGONISTS; CAUSE OF DEATH; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; FOLLOW-UP STUDIES; HOSPITAL MORTALITY; HYPOLIPIDEMIC AGENTS; INPATIENTS; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE COMPLICATIONS; QUALITY IMPROVEMENT; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; UNITED STATES;

EID: 84880326069     PISSN: 19327501     EISSN: 1932751X     Source Type: Journal    
DOI: 10.1097/HCR.0b013e3182930cd0     Document Type: Article

References (21)

1. Ferguson TB Jr, Hammill BG, Peterson ED, DeLong ER, Grover FL. A decade of change-risk profiles and outcomes for isolated coronary artery bypass grafting procedures, 1990-1999:A report from the STS National Database Committee and the Duke Clinical Research Institute. Society of Thoracic Surgeons. Ann Thorac Surg. 2002;73:480-489.
2. Bradshaw PJ, Jamrozik K, Le M, Gilfillan I, Thompson PL. Mortality and recurrent cardiac events after coronary artery bypass graft:long term outcomes in a population study. Heart. 2002;88:488-494.
3. Bradshaw PJ, Jamrozik K, Gilfillan I, Thompson PL. Preventing recurrent events long term after coronary artery bypass graft:suboptimal use of medications in a population study. Am Heart J. 2004;147:1047-1053.
4. Foody JM, Ferdinand FD, Galusha D, et al. Patterns of secondary prevention in older patients undergoing coronary artery bypass grafting during hospitalization for acute myocardial infarction. Circulation. 2003;108 (suppl 1):II24-II28.
5. Okrainec K, Pilote L, Platt R, Eisenberg MJ. Use of cardiovascular medical therapy among patients undergoing coronary artery bypass graft surgery:results from the ROSETTA-CABG registry. Can J Cardiol. 2006;22:841-847.
6. Filion KB, Pilote L, Rahme E, Eisenberg MJ. Use of periopera-tive cardiac medical therapy among patients undergoing coronary artery bypass graft surgery. J Card Surg. 2008;23:209-215.
7. Fonarow GC, Gawlinski A, Moughrabi S, Tillisch JH. Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP). Am J Cardiol. 2001;87:819-822
8. Hiratzka LF, Eagle KA, Liang L, Fonarow GC, LaBresh KA, Peterson ED. Atherosclerosis secondary prevention performance measures after coronary bypass graft surgery compared with percutaneous catheter intervention and nonintervention patients in the Get With the Guidelines database. Circulation. 2007;116 (11)(suppl):I207-I212.
9. Accurint. A LexisNexis commercial location and research online service. http://www.accurint.com. Published 2008. Accessed April 23, 2013.
10. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. New Engl J Med. 2006;355:251-259.
11. Ferguson TB, Jr Peterson ED, Coombs LP, et al. Use of continuous quality improvement to increase use of process measures in patients undergoing coronary artery bypass graft surgery:A randomized controlled trial. JAMA. 2003;290:49-56.
12. Holman WL, Allman RM, Sansom M, et al. Alabama coronary artery bypass grafting project:results of a statewide quality improvement initiative. JAMA. 2001;285:3003-3010.
13. O'Connor GT, Plume SK, Olmstead EM, et al. A regional intervention to improve the hospital mortality associated with coronary artery bypass graft surgery. The Northern New England Cardiovascular Disease Study Group. JAMA. 1996;275:841-846.
14. Suaya JA, Shepard DS, Normand SL, Ades PA, Prottas J, Stason WB. Use of cardiac rehabilitation by Medicare beneficiaries after myocardial infarction or coronary bypass surgery. Circulation. 2007;116:1653-1662
15. The Post Coronary Artery Bypass Graft Trial Investigators. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts. N Engl J Med. 1997;336:153-162.
16. Goyal A, Alexander JH, Hafley GE, et al. Outcomes associated with the use of secondary prevention medications after coronary artery bypass graft surgery. Ann Thorac Surg. 2007;83:993-1001.
17. Khanderia U, Townsend KA, Eagle K, Prager R. Statin initiation following coronary artery bypass grafting:outcome of a hospital discharge protocol. Chest. 2005;127:455-463.
18. Yam FK, Akers WS, Ferraris V A, et al. Interventions to improve guideline compliance following coronary artery bypass grafting. Surgery. 2006;140:541-547.
19. Brush JE Jr, Balakrishnan SA, Brough J, et al. Implementation of a continuous quality improvement program for percutaneous coronary intervention and cardiac surgery at a large community hospital. Am Heart J. 2006;152:379-385.
20. Solberg LI, Kottke TE, Brekke ML, et al. Failure of a continuous quality improvement intervention to increase the delivery of preventive services. A randomized trial. Eff Clin Pract. 2000;3:105-115.
21. Berwick DM. Continuous improvement as an ideal in health care. N Engl J Med. 1989;320:53-56.